1	c-Ski	c-Ski	B-NP	NN	B-protein	2	NMOD	-1
2	overexpression	overexpression	I-NP	NN	O	3	SUB	9	overexpression
3	promotes	promote	B-VP	VBZ	O	0	ROOT	17	promotes
4	tumor	tumor	B-NP	NN	O	5	NMOD	-1
5	growth	growth	I-NP	NN	O	7	NMOD	4	growth
6	and	and	I-NP	CC	O	7	NMOD	-1
7	angiogenesis	angiogenesis	I-NP	NN	O	3	OBJ	3	angiogenesis
8	through	through	B-PP	IN	O	3	VMOD	0
9	inhibition	inhibition	B-NP	NN	O	8	PMOD	18	inhibition
10	of	of	B-PP	IN	O	9	NMOD	-1
11	transforming	transform	B-NP	VBG	B-protein	13	NMOD	-1
12	growth	growth	I-NP	NN	I-protein	13	NMOD	0
13	factor-beta	factor-beta	I-NP	NN	I-protein	14	NMOD	-1
14	signaling	signaling	I-NP	NN	O	10	PMOD	0
15	in	in	B-PP	IN	O	9	NMOD	-1
16	diffuse-type	diffuse-type	B-NP	JJ	O	18	NMOD	-1
17	gastric	gastric	I-NP	JJ	O	18	NMOD	-1
18	carcinoma	carcinoma	I-NP	NN	O	15	PMOD	-1
19	.	.	O	.	O	3	P	-1

1	c-Ski	c-Ski	B-NP	NN	B-protein	10	SUB	-1
2	,	,	O	,	O	1	P	-1
3	originally	originally	B-VP	RB	O	4	VMOD	-1
4	identified	identify	I-VP	VBN	O	1	NMOD	-1
5	as	as	B-PP	IN	O	4	VMOD	-1
6	a	a	B-NP	DT	O	8	NMOD	-1
7	proto-oncogene	proto-oncogene	I-NP	NN	B-protein	8	NMOD	-1
8	product	product	I-NP	NN	I-protein	5	PMOD	-1
9	,	,	O	,	O	1	P	-1
10	is	be	B-VP	VBZ	O	0	ROOT	-1
11	an	an	B-NP	DT	O	14	NMOD	-1
12	important	important	I-NP	JJ	O	14	NMOD	0
13	negative	negative	I-NP	JJ	O	14	NMOD	0
14	regulator	regulator	I-NP	NN	O	10	PRD	0
15	of	of	B-PP	IN	O	14	NMOD	-1
16	transforming	transform	B-VP	VBG	B-protein	24	NMOD	-1
17	growth	growth	B-NP	NN	I-protein	24	NMOD	0
18	factor	factor	I-NP	NN	I-protein	24	NMOD	-1
19	(	(	O	(	I-protein	24	NMOD	-1
20	TGF	TGF	B-NP	NN	I-protein	24	NMOD	-1
21	)	)	O	)	I-protein	24	NMOD	-1
22	-beta	-beta	B-NP	NN	I-protein	24	NMOD	-1
23	family	family	I-NP	NN	I-protein	24	NMOD	-1
24	signaling	signaling	I-NP	NN	O	15	PMOD	0
25	through	through	B-PP	IN	O	10	VMOD	0
26	interaction	interaction	B-NP	NN	O	25	PMOD	15	interaction
27	with	with	B-PP	IN	O	26	NMOD	-1
28	Smad2	Smad2	B-NP	NN	B-protein	33	NMOD	-1
29	,	,	O	,	O	33	P	-1
30	Smad3	Smad3	B-NP	NN	B-protein	33	NMOD	-1
31	,	,	O	,	O	33	P	-1
32	and	and	O	CC	O	33	NMOD	-1
33	Smad4	Smad4	B-NP	NN	B-protein	27	PMOD	-1
34	.	.	O	.	O	10	P	-1

1	High	High	B-NP	JJ	O	2	NMOD	-1
2	expression	expression	I-NP	NN	O	5	SUB	9	expression
3	of	of	B-PP	IN	O	2	NMOD	-1
4	c-Ski	c-Ski	B-NP	NN	B-protein	3	PMOD	-1
5	has	have	B-VP	VBZ	O	0	ROOT	-1
6	been	be	I-VP	VBN	O	5	VC	-1
7	found	find	I-VP	VBN	O	6	VC	0
8	in	in	B-PP	IN	O	7	VMOD	-1
9	some	some	B-NP	DT	O	10	NMOD	-1
10	cancers	cancer	I-NP	NNS	O	8	PMOD	-1
11	,	,	O	,	O	10	P	-1
12	including	include	B-PP	VBG	O	10	NMOD	-1
13	gastric	gastric	B-NP	JJ	O	14	NMOD	-1
14	cancer	cancer	I-NP	NN	O	12	PMOD	-1
15	.	.	O	.	O	5	P	-1

1	We	We	B-NP	PRP	O	3	SUB	-1
2	previously	previously	B-ADVP	RB	O	3	VMOD	-1
3	showed	show	B-VP	VBD	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	disruption	disruption	B-NP	NN	O	21	SUB	18	disruption
6	of	of	B-PP	IN	O	5	NMOD	-1
7	TGF-beta	TGF-beta	B-NP	NN	B-protein	8	NMOD	-1
8	signaling	signaling	I-NP	NN	O	6	PMOD	0
9	by	by	B-PP	IN	O	5	NMOD	-1
10	dominant-negative	dominant-negative	B-NP	JJ	B-protein	14	NMOD	-1
11	TGF-beta	TGF-beta	I-NP	NN	I-protein	14	NMOD	-1
12	type	type	I-NP	NN	I-protein	14	NMOD	-1
13	II	II	I-NP	CD	I-protein	14	NMOD	-1
14	receptor	receptor	I-NP	NN	I-protein	9	PMOD	-1
15	in	in	B-PP	IN	O	5	NMOD	-1
16	a	a	B-NP	DT	O	20	NMOD	-1
17	diffuse-type	diffuse-type	I-NP	JJ	O	20	NMOD	-1
18	gastric	gastric	I-NP	JJ	O	20	NMOD	-1
19	carcinoma	carcinoma	I-NP	NN	O	20	NMOD	-1
20	model	model	I-NP	NN	O	15	PMOD	-1
21	accelerated	accelerate	B-VP	VBD	O	4	SBAR	17	accelerated
22	tumor	tumor	B-NP	NN	O	23	NMOD	-1
23	growth	growth	I-NP	NN	O	21	OBJ	4	growth
24	through	through	B-PP	IN	O	21	VMOD	0
25	induction	induction	B-NP	NN	O	24	PMOD	17	induction
26	of	of	B-PP	IN	O	25	NMOD	-1
27	tumor	tumor	B-NP	NN	O	28	NMOD	-1
28	angiogenesis	angiogenesis	I-NP	NN	O	26	PMOD	3	angiogenesis
29	by	by	B-PP	IN	O	25	NMOD	-1
30	decreased	decrease	B-NP	VBN	O	31	NMOD	18	decreased
31	expression	expression	I-NP	NN	O	29	PMOD	9	expression
32	of	of	B-PP	IN	O	31	NMOD	-1
33	the	the	B-NP	DT	O	38	NMOD	-1
34	anti-angiogenic	anti-angiogenic	I-NP	JJ	B-protein	38	NMOD	3	angiogenic
35	factor	factor	I-NP	NN	I-protein	38	NMOD	-1
36	thrombospondin	thrombospondin	I-NP	NN	I-protein	38	NMOD	-1
37	(	(	O	(	I-protein	38	NMOD	-1
38	TSP	TSP	B-NP	NN	I-protein	32	PMOD	-1
39	)	)	O	)	I-protein	38	NMOD	-1
40	-1	-1	B-NP	CD	I-protein	38	NMOD	-1
41	.	.	O	.	O	3	P	-1

1	Here	Here	B-ADVP	RB	O	4	VMOD	-1
2	,	,	O	,	O	4	P	-1
3	we	we	B-NP	PRP	O	4	SUB	-1
4	examined	examine	B-VP	VBD	O	0	ROOT	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	function	function	I-NP	NN	O	4	OBJ	-1
7	of	of	B-PP	IN	O	6	NMOD	-1
8	c-Ski	c-Ski	B-NP	NN	B-protein	7	PMOD	-1
9	in	in	B-PP	IN	O	6	NMOD	-1
10	human	human	B-NP	JJ	B-cell_type	15	NMOD	-1
11	diffuse-type	diffuse-type	I-NP	JJ	I-cell_type	15	NMOD	-1
12	gastric	gastric	I-NP	JJ	I-cell_type	15	NMOD	-1
13	carcinoma	carcinoma	I-NP	NN	I-cell_type	15	NMOD	-1
14	OCUM-2MLN	OCUM-2MLN	I-NP	NN	I-cell_type	15	NMOD	-1
15	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	-1
16	.	.	O	.	O	4	P	-1

1	Overexpression	Overexpression	B-NP	NN	O	4	SUB	9	Overexpression
2	of	of	B-PP	IN	O	1	NMOD	-1
3	c-Ski	c-Ski	B-NP	NN	B-protein	2	PMOD	-1
4	inhibited	inhibit	B-VP	VBD	O	0	ROOT	18	inhibited
5	TGF-beta	TGF-beta	B-NP	NN	B-protein	6	NMOD	-1
6	signaling	signaling	I-NP	NN	O	4	OBJ	0
7	in	in	B-PP	IN	O	6	NMOD	-1
8	OCUM-2MLN	OCUM-2MLN	B-NP	NN	B-cell_line	9	NMOD	-1
9	cells	cell	I-NP	NNS	I-cell_line	7	PMOD	-1
10	.	.	O	.	O	4	P	-1

1	Interestingly	Interestingly	B-ADVP	RB	O	5	VMOD	-1
2	,	,	O	,	O	5	P	-1
3	c-Ski	c-Ski	B-NP	NN	B-protein	4	NMOD	-1
4	overexpression	overexpression	I-NP	NN	O	5	SUB	9	overexpression
5	resulted	result	B-VP	VBD	O	0	ROOT	0
6	in	in	B-PP	IN	O	5	VMOD	-1
7	extensive	extensive	B-NP	JJ	O	8	NMOD	-1
8	acceleration	acceleration	I-NP	NN	O	6	PMOD	-1
9	of	of	B-PP	IN	O	8	NMOD	-1
10	the	the	B-NP	DT	O	11	NMOD	-1
11	growth	growth	I-NP	NN	O	9	PMOD	4	growth
12	of	of	B-PP	IN	O	11	NMOD	-1
13	subcutaneous	subcutaneous	B-NP	JJ	O	14	NMOD	-1
14	xenografts	xenograft	I-NP	NNS	O	12	PMOD	-1
15	in	in	B-PP	IN	O	8	NMOD	-1
16	BALB/c	BALB/c	B-NP	NN	O	19	NMOD	-1
17	nu/nu	nu/nu	I-NP	NN	O	19	NMOD	-1
18	female	female	I-NP	JJ	O	19	NMOD	-1
19	mice	mouse	I-NP	NNS	O	15	PMOD	-1
20	(	(	O	(	O	25	DEP	-1
21	6	6	B-NP	CD	O	22	NMOD	-1
22	weeks	week	I-NP	NNS	O	25	DEP	-1
23	of	of	B-PP	IN	O	22	NMOD	-1
24	age	age	B-NP	NN	O	23	PMOD	-1
25	)	)	O	)	O	19	NMOD	-1
26	.	.	O	.	O	5	P	-1

1	Similar	Similar	B-ADJP	JJ	O	13	VMOD	-1
2	to	to	B-PP	TO	O	1	AMOD	-1
3	tumors	tumor	B-NP	NNS	O	2	PMOD	-1
4	expressing	express	B-VP	VBG	O	3	NMOD	9	expressing
5	dominant-negative	dominant-negative	B-NP	JJ	B-protein	9	NMOD	-1
6	TGF-beta	TGF-beta	I-NP	NN	I-protein	9	NMOD	-1
7	type	type	I-NP	NN	I-protein	9	NMOD	-1
8	II	II	I-NP	CD	I-protein	9	NMOD	-1
9	receptor	receptor	I-NP	NN	I-protein	4	OBJ	-1
10	,	,	O	,	O	13	P	-1
11	histochemical	histochemical	B-NP	JJ	O	12	NMOD	-1
12	studies	study	I-NP	NNS	O	13	SUB	-1
13	revealed	reveal	B-VP	VBD	O	0	ROOT	-1
14	less	less	B-NP	JJR	O	15	NMOD	-1
15	fibrosis	fibrosis	I-NP	NN	O	18	NMOD	-1
16	and	and	O	CC	O	18	NMOD	-1
17	increased	increase	B-NP	VBN	O	18	NMOD	17	increased
18	angiogenesis	angiogenesis	I-NP	NN	O	13	OBJ	3	angiogenesis
19	in	in	B-PP	IN	O	18	NMOD	-1
20	xenografted	xenografte	B-NP	VBN	O	21	NMOD	-1
21	tumors	tumor	I-NP	NNS	O	19	PMOD	-1
22	expressing	express	B-VP	VBG	O	21	NMOD	9	expressing
23	c-Ski	c-Ski	B-NP	NN	B-protein	22	OBJ	-1
24	compared	compare	B-VP	VBN	O	21	NMOD	-1
25	to	to	I-VP	TO	O	26	VMOD	-1
26	control	control	I-VP	VB	O	24	VMOD	0
27	tumors	tumor	B-NP	NNS	O	26	OBJ	-1
28	.	.	O	.	O	13	P	-1

1	Induction	Induction	B-NP	NN	O	7	SUB	17	Induction
2	of	of	B-PP	IN	O	1	NMOD	-1
3	TSP-1	TSP-1	B-NP	NN	B-RNA	4	NMOD	-1
4	mRNA	mRNA	I-NP	NN	I-RNA	2	PMOD	0
5	by	by	B-PP	IN	O	1	NMOD	-1
6	TGF-beta	TGF-beta	B-NP	NN	B-protein	5	PMOD	-1
7	was	be	B-VP	VBD	O	19	VMOD	-1
8	attenuated	attenuate	I-VP	VBN	O	7	VC	18	attenuated
9	by	by	B-PP	IN	O	8	VMOD	-1
10	c-Ski	c-Ski	B-NP	NN	B-protein	9	PMOD	-1
11	in	in	B-ADVP	FW	O	8	VMOD	-1
12	vitro	vitro	I-ADVP	FW	O	11	AMOD	-1
13	,	,	O	,	O	19	P	-1
14	and	and	O	CC	O	15	NMOD	-1
15	expression	expression	B-NP	NN	O	19	SUB	10	expression
16	of	of	B-PP	IN	O	15	NMOD	-1
17	TSP-1	TSP-1	B-NP	NN	B-RNA	18	NMOD	-1
18	mRNA	mRNA	I-NP	NN	I-RNA	16	PMOD	0
19	was	be	B-VP	VBD	O	0	ROOT	-1
20	decreased	decrease	I-VP	VBN	O	19	VC	18	decreased
21	in	in	B-PP	IN	O	20	VMOD	-1
22	tumors	tumor	B-NP	NNS	O	21	PMOD	-1
23	expressing	express	B-VP	VBG	O	22	NMOD	9	expressing
24	c-Ski	c-Ski	B-NP	NN	B-protein	23	OBJ	-1
25	in	in	B-ADVP	FW	O	23	VMOD	-1
26	vivo	vivo	I-ADVP	FW	O	25	AMOD	-1
27	.	.	O	.	O	19	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	findings	finding	I-NP	NNS	O	3	SUB	-1
3	suggest	suggest	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	c-Ski	c-Ski	B-NP	NN	B-protein	6	NMOD	-1
6	overexpression	overexpression	I-NP	NN	O	7	SUB	9	overexpression
7	promotes	promote	B-VP	VBZ	O	4	SBAR	17	promotes
8	the	the	B-NP	DT	O	9	NMOD	-1
9	growth	growth	I-NP	NN	O	7	OBJ	4	growth
10	of	of	B-PP	IN	O	9	NMOD	-1
11	diffuse-type	diffuse-type	B-NP	JJ	O	13	NMOD	-1
12	gastric	gastric	I-NP	JJ	O	13	NMOD	-1
13	carcinoma	carcinoma	I-NP	NN	O	10	PMOD	-1
14	through	through	B-PP	IN	O	7	VMOD	0
15	induction	induction	B-NP	NN	O	14	PMOD	17	induction
16	of	of	B-PP	IN	O	15	NMOD	-1
17	angiogenesis	angiogenesis	B-NP	NN	O	16	PMOD	3	angiogenesis
